Sai Parenterals Latest Share Price (SAIPARENT)
TODAY IN ONE LINE
SAIPARENT is little changed at ₹527.90 — a quiet consolidation day.
With a market cap of ₹2,332.66 Cr., it trades at a P/E of 163.47. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Sai Parenterals flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 51.2% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 4.9%
- ●Expensive ValuationTrading at a high P/E ratio of 191.1x
Latest Sai Parenterals News
What changed recently?
Recent events, corporate actions, and announcements.
Sai Parenterals Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Sai Parenterals Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Sai Parenterals Ltd trades at a P/E of 163.47× and P/B of 4.75×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Sai Parenterals Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Sai Parenterals Ltd — derived from the latest tape, not yesterday's close.
Sai Parenterals Ltd last traded at ₹527.9 with an intraday range of ₹518.3–₹531.95 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹527.90| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 561.10 | +33.20 | +6.29% |
| R3 | 547.45 | +19.55 | +3.70% |
| R2 | 539.70 | +11.80 | +2.24% |
| R1 | 533.80 | +5.90 | +1.12% |
| PIVOT | 526.05 | -1.85 | -0.35% |
| CURRENT | 527.90 | — | — |
| S1 | 520.15 | -7.75 | -1.47% |
| S2 | 512.40 | -15.50 | -2.94% |
| S3 | 506.50 | -21.40 | -4.05% |
| S4 | 492.85 | -35.05 | -6.64% |
SAIPARENT is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹523.05–₹528.75
Trading Inside opening range
Sai Parenterals Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Sai Parenterals Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Sai Parenterals Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,332.66 Cr. and reported EPS of ₹3.23.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 381 |
| Other Income | — | 9 |
| Total Income | — | 390 |
| — | 242 | |
| Gross ProfitDerived | — | 139 |
| Gross Margin %Derived | — | 36.42% |
| — | 100 | |
| EBITDA (Operating Profit)Derived | — | 39 |
| OPM %Derived | — | 10.16% |
| — | 35 | |
| Profit Before Tax (PBT) | — | 12 |
| — | -2 | |
| Effective Tax %Derived | — | -19.54% |
| Total Profit for Period | — | 14 |
| Net Profit (Owner's PAT)Derived | — | 14 |
| Net Profit Margin %Derived | — | 3.74% |
| Earnings Per Share (EPS ₹) | — | 3.23 |
| Diluted Shares Outstanding (Cr) | — | 4 |
| Other Comprehensive Income (Net of Tax) | — | 0 |
| Total Expenses (incl. D&A & Interest) | — | 378 |
| Material Cost % of RevenueDerived | — | 62.50% |
| Employee Cost % of RevenueDerived | — | 7.69% |
| Other Cost % of RevenueDerived | — | 18.58% |
| Interest Coverage (x)Derived | — | 1.18x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 381 | |
| Other Income | 9 | |
| Total Income | 390 | |
242 | ||
| Gross ProfitDerived | 139 | |
| Gross Margin %Derived | 36.42% | |
100 | ||
| EBITDA (Operating Profit)Derived | 39 | |
| OPM %Derived | 10.16% | |
35 | ||
| Profit Before Tax (PBT) | 12 | |
-2 | ||
| Effective Tax %Derived | -19.54% | |
| Total Profit for Period | 14 | |
| Net Profit (Owner's PAT)Derived | 14 | |
| Net Profit Margin %Derived | 3.74% | |
| Earnings Per Share (EPS ₹) | 3.23 | |
| Diluted Shares Outstanding (Cr) | 4 | |
| Other Comprehensive Income (Net of Tax) | 0 | |
| Total Expenses (incl. D&A & Interest) | 378 | |
| Material Cost % of RevenueDerived | 62.50% | |
| Employee Cost % of RevenueDerived | 7.69% | |
| Other Cost % of RevenueDerived | 18.58% | |
| Interest Coverage (x)Derived | 1.18x |
Sai Parenterals segment analysis : revenue and profit mix.
Disclosed business segments at Sai Parenterals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Sai Parenterals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Sai Parenterals Ltd.
Our AI distills the core fundamental drivers supporting Sai Parenterals Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 213 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.18. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Sai Parenterals Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Sai Parenterals Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Sai Parenterals Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Sai Parenterals Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Sai Parenterals Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Sai Parenterals Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Sai Parenterals Ltd stood at 60.3% of traded volume, against a 20-day average of 59.1%.
Sai Parenterals announcements: results, concalls, ratings, M&A.
Filings Sai Parenterals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Sai Parenterals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 29 documents below.
Copy of Newspaper Publication
Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.
Copy of Newspaper Publication
Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds
General Updates
Sai Parenterals Limited has informed the Exchange about Intimation of Book closure and cutoff date for the 25th Annual General Meeting
Shareholders meeting
Sai Parenterals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 10, 2026
Analysts/Institutional Investor Meet/Con. Call Updates
Sai Parenterals Limited has informed the Exchange about Transcript
Investor decks & rating reports.
Sai Parenterals dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Sai Parenterals has declared, sequenced by announce and record date.
Sai Parenterals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Sai Parenterals Ltd: business, sector, key facts.
What Sai Parenterals Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Sai Parenterals Ltd is a listed Indian equity, listed as NSE: SAIPARENT, BSE: 544742.
Sai Parenterals Ltd
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Sai Parenterals Ltd (SAIPARENT).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Sai Parenterals Ltd (SAIPARENT)?
The current share price of Sai Parenterals Ltd (SAIPARENT) is ₹527.90. Today, the stock has declined by ₹0.85 (0.16%), trading in a range of ₹518.30 to ₹531.95. The stock opened at ₹525.05 with a trading volume of 82,571 shares.
02Is Sai Parenterals Ltd stock a good investment for long-term?
Sai Parenterals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,332.66 Cr., P/E ratio of 163.47, ROE of 4.88%, and ROCE of 5.97%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Sai Parenterals Ltd stock?
The 52-week high price of Sai Parenterals Ltd (SAIPARENT) is ₹706.00, while the 52-week low is ₹400.00. Currently trading at ₹527.90, the stock is 31.97% above its 52-week low and 25.23% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Sai Parenterals Ltd stock at the current price?
Whether to buy Sai Parenterals Ltd stock at ₹527.90 depends on multiple factors. The stock is currently trading with a P/E ratio of 163.47 and P/B ratio of 4.75. Today's performance shows a loss of 0.16%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Sai Parenterals Ltd and when is the next dividend?
Sai Parenterals Ltd offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹527.90, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Sai Parenterals Ltd?
Sai Parenterals Ltd's key financial metrics include: P/E Ratio: 163.47, P/B Ratio: 4.75, ROE: 4.88%, ROCE: 5.97%, Dividend Yield: 0%, EPS: ₹3.23, Book Value: ₹0.00, and Debt-to-Equity: 0.68. The company's market cap stands at ₹2,332.66 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Sai Parenterals Ltd stock performing today in the market?
Sai Parenterals Ltd stock opened at ₹525.05 and is currently trading at ₹527.90, showing a decline of ₹0.85 (0.16%). The intraday high is ₹531.95 and low is ₹518.30. The trading volume stands at 82,571 shares, indicating moderate market participation today.
08What is the P/E ratio of Sai Parenterals Ltd and what does it indicate?
Sai Parenterals Ltd has a Price-to-Earnings (P/E) ratio of 163.47, which means investors are willing to pay 163.47 for every ₹1 of earnings. With an EPS of ₹3.23, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Sai Parenterals Ltd (SAIPARENT) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.